Clinical Trials
8 trialsNCT03123978 2026-05-06
Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer
University of California, Davis
Phase 1 Completed
NCT05188170 2026-01-12
Niclosamide in Pediatric Patients With Relapsed and Refractory AML
Stanford University
Phase 1 Recruiting
NCT04870333 2025-06-20
PROTECT-V
Cambridge University Hospitals NHS Foundation Trust
Phase 2/3 Completed
NCT02807805 2024-12-18
Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
University of California, Davis
Phase 2 Active not recruiting
NCT04296851 2020-03-05
Niclosamide for Familial Adenomatous Polyposis
Yonsei University
Phase 2 Unknown
NCT02687009 2020-02-19
A Study of Niclosamide in Patients With Resectable Colon Cancer
Duke University
Phase 1 Terminated
NCT02519582 2018-09-12
Nikolo
Charite University, Berlin, Germany
Phase 2 Unknown
NCT02532114 2018-04-18
Niclosamide and Enzalutamide in Treating Patients With Castration-Resistant, Metastatic Prostate Cancer
University of Washington
Phase 1 Completed